Search

everythinglearnresearchcommunity

for

Search:↓

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

DNA can predict physical traits like eye and hair color accurately, especially in Europeans, but predicting other traits and in diverse populations needs more research.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Animal models are crucial for learning about hair loss and finding treatments.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Heavily hunted wolves have higher stress and reproductive hormone levels.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Different processes create patterns in skin and things like hair and feathers.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Crossbreeding improves goat fiber quality, and specific genes affect hair traits and color.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Lower SHBG levels may increase the risk of PCOS.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.